ALG-055009 dose groups met the primary endpoint with statistically significant reductions in liver fat at Week 12 as measured ...

Aligos Therapeutics (ALGS) stock slips as company releases Phase 2a results for liver drug ALG-055009 in MASH. Read more here ...

Aligos Therapeutics is heralding a midstage win in metabolic-dysfunction associated steatohepatitis (MASH) after three ...

Aligos Therapeutics, Inc. (ALGS), a clinical stage biopharmaceutical company focused on liver and viral diseases, announced Thursday ...

Performed in an advanced Magnetic Resonance Imaging (MRI ... By offering this state-of-the-art treatment, Evolution Imaging and Oklahoma Proton Center aim to improve patient outcomes while reducing ...

Molecular imaging holds promise for liver fibrosis grading but limited by a lack of effective biomarker. Here, the authors discover the grading potential of fibroblast activation protein alpha and ...

The liver function in post-cardiac arrest brain injury is not known and was investigated in a pig model of global cerebral ...

Non-invasive examination of the body by means of NMR is extensive and has many useful applications, particularly with Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS).

Sep. 10, 2024 — Researchers have published a novel study exploring the effects of delayed feedback on learning in individuals with moderate-to-severe traumatic brain ... Sep. 5, 2024 — Staging ...

Keywords: Multimodal MRI, Cognitive impairment, Alzheimer's disease, Diffusion tensor imaging (DTI), Functional MRI (fMRI), Structural MRI, Brain networks, Magnetic resonance spectroscopy (MRS), ...

Proton is taking great pains to stress that its forthcoming eMas 7 (stylised as the e.MAS 7) is not a mere rebadge of its Geely Galaxy E5/EX5 twin, highlighting the significant amount of local input.